Treatment of the neuroleptic malignant syndrome with bromocriptine.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use*; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D001971:Bromocriptine; C011825:fluphenazine depot; D005476:Fluphenazine